Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$1.17B |
| 2 |
Ferrari
RACE
|
+$497M |
| 3 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$371M |
| 4 |
Under Armour
UAA
|
+$348M |
| 5 |
APA Corp
APA
|
+$309M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$513M |
| 2 |
M&T Bank
MTB
|
+$486M |
| 3 |
Harley-Davidson
HOG
|
+$379M |
| 4 |
Intuitive Surgical
ISRG
|
+$364M |
| 5 |
PayPal
PYPL
|
+$345M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 32.5% |
| 2 | Communication Services | 21.06% |
| 3 | Healthcare | 12.98% |
| 4 | Financials | 9.34% |
| 5 | Technology | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCRH
151
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $11.3M | 0.02% |
629,438
| – | – |
|
152
HEICO Corp
HEI
$51.4B
| $11M | 0.02% |
448,218
-17,300
| -4% | -$398K |
|
|
EVF
153
Eaton Vance Senior Income Trust
EVF
$90.7M
| $10.9M | 0.02% |
1,885,000
| – | – |
|
154
Veeco
VECO
$3.28B
| $10.8M | 0.02% |
552,644
+137,256
| +33% | +$2.52M |
|
155
Estee Lauder
EL
$31.5B
| $10.5M | 0.02% |
111,584
| – | – |
|
156
PACCAR
PCAR
$71.6B
| $10.1M | 0.02% |
276,371
+28,322
| +11% | +$949K |
|
|
AFT
157
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
| $9.39M | 0.02% |
617,746
| – | – |
|
158
Donaldson
DCI
$11.4B
| $9.26M | 0.02% |
290,081
+26,526
| +10% | +$779K |
|
159
Sherwin-Williams
SHW
$87.8B
| $8.89M | 0.02% |
93,708
+19,266
| +26% | +$1.69M |
|
160
SLB Ltd
SLB
$75.4B
| $8.79M | 0.02% |
119,127
| – | – |
|
161
LendingTree
TREE
$474M
| $8.09M | 0.01% |
+82,700
| New | +$6.46M |
|
|
VAR
162
DELISTED
Varian Medical Systems, Inc.
VAR
| $8.05M | 0.01% |
114,799
| – | – |
|
|
NVDQ
163
DELISTED
Novadaq Technologies Inc.
NVDQ
| $7.81M | 0.01% |
704,480
| – | – |
|
|
SCTY
164
DELISTED
SolarCity Corporation
SCTY
| $7.69M | 0.01% |
312,900
| – | – |
|
165
AeroVironment
AVAV
$8.55B
| $6.48M | 0.01% |
228,710
-35,000
| -13% | -$913K |
|
|
ELLI
166
DELISTED
Ellie Mae Inc
ELLI
| $6.43M | 0.01% |
71,000
+50,000
| +238% | +$3.74M |
|
167
Wipro
WIT
$20.3B
| $6.32M | 0.01% |
2,677,851
-617,616
| -19% | -$1.35M |
|
|
NATI
168
DELISTED
National Instruments Corp
NATI
| $6.07M | 0.01% |
201,470
+10,000
| +5% | +$287K |
|
|
CSLT
169
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $5.98M | 0.01% |
1,794,820
| – | – |
|
|
170
PayPal
PYPL
$50.1B
| $5.87M | 0.01% |
151,960
-9,556,320
| -98% | -$345M |
|
171
Berkshire Hathaway Class B
BRK.B
$1.12T
| $5.85M | 0.01% |
41,243
-760,330
| -95% | -$101M |
|
|
EXA
172
DELISTED
EXA Corporation
EXA
| $5.43M | 0.01% |
419,630
| – | – |
|
173
Protalix BioTherapeutics
PLX
$191M
| $5.38M | 0.01% |
640,610
| – | – |
|
174
Digimarc Corp
DMRC
$166M
| $4.68M | 0.01% |
154,500
+40,000
| +35% | +$1.28M |
|
175
US Bancorp
USB
$100B
| $4.22M | 0.01% |
104,000
-1,664,277
| -94% | -$66.4M |
|
Similar funds
Baillie Gifford & Co's Q1 2016 Portfolio in Review
As of Q1 2016, Baillie Gifford & Co held 206 positions worth $56.8B, down 1.2% from $57.5B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Baillie Gifford & Co deployed $1.91B of net new capital in Q1 2016, opening 24 new positions and adding to 85 existing holdings. Its largest new stake was TSMC: 49,857,061 shares worth $1.31B.
By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, down from 34% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Stellantis, an estimated $513M trimmed.
- Baillie Gifford & Co's largest Q1 2016 buy was TSMC: 49,857,061 shares worth $1.31B.
- Baillie Gifford & Co added most to Juno Therapeutics, Inc. in Q1 2016, an estimated $371M increase.
- Baillie Gifford & Co's biggest Q1 2016 reduction was Stellantis, cutting an estimated $513M.
- Baillie Gifford & Co fully exited MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q1 2016, selling an estimated $136M.
- Baillie Gifford & Co's ten largest holdings make up 49% of its $56.8B portfolio in Q1 2016.
- Baillie Gifford & Co opened 24 new positions and closed 9 in Q1 2016.
- Baillie Gifford & Co's portfolio value fell 1.2% quarter-over-quarter to $56.8B.
Based on Baillie Gifford & Co's 13F filing for Q1 2016, filed 5 May 2016.